{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:06:03Z","timestamp":1790885163413,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Problems in Cancer"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1067\/mcn.2001.117539","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"224-278","source":"Crossref","is-referenced-by-count":123,"title":["Diagnosis and management of superficial bladder cancer"],"prefix":"10.1067","volume":"25","author":[{"given":"Christopher L.","family":"Amling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mcn.2001.117539_BIB1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics, 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/mcn.2001.117539_BIB2","first-page":"282","article-title":"Epidemiology of bladder cancer","author":"Schatte","year":"2000"},{"key":"10.1067\/mcn.2001.117539_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0094-0143(05)70229-9","article-title":"The natural history of bladder cancer; implications for therapy","volume":"27","author":"Lee","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0094-0143(21)00411-0","article-title":"Natural history of superficial bladder cancer: prognostic features and long-term disease course","volume":"19","author":"Heney","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/jnci\/81.19.1480","article-title":"Occupational risks of bladder cancer in the United States-II: nonwhite men","volume":"81","author":"Silverman","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mcn.2001.117539_BIB6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/81.19.1472","article-title":"Occupational risks of bladder cancer in the United States. I. White men","volume":"81","author":"Silverman","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mcn.2001.117539_BIB7","first-page":"588","article-title":"Blasengeschwulste bei Fuchsin-Arbeitern","volume":"50","author":"Rehn","year":"1895","journal-title":"Arch Clin Chir"},{"key":"10.1067\/mcn.2001.117539_BIB8","first-page":"40","article-title":"Experimental production of bladder tumors in dogs by administration of beta-naphthylamine","volume":"20","author":"Hueper","year":"1938","journal-title":"J Ind Hyg Toxicol"},{"key":"10.1067\/mcn.2001.117539_BIB9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/1097-0142(19820301)49:5<1056::AID-CNCR2820490535>3.0.CO;2-I","article-title":"Concepts in causality: chemically induced human urinary bladder cancer","volume":"49","author":"Lower","year":"1982","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/carcin\/6.2.199","article-title":"N-acetyl-transferase phenotypes in the urinary bladder cacinogenisis of a low risk population","volume":"6","author":"Mommsen","year":"1985","journal-title":"Carcinogenisis"},{"key":"10.1067\/mcn.2001.117539_BIB11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/jnci\/82.23.1826","article-title":"Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers","volume":"82","author":"Bartsch","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mcn.2001.117539_BIB12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archinte.1956.00250260001001","article-title":"The association of smoking with cancer of the urinary bladder in humans","volume":"98","author":"Lillienfield","year":"1956","journal-title":"Arch Intern Med"},{"key":"10.1067\/mcn.2001.117539_BIB13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ijc.2910440408","article-title":"Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco","volume":"44","author":"Clavel","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB14","first-page":"1119","article-title":"Changing cigarette habits and bladder cancer risk: a case control study","volume":"78","author":"Hartge","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mcn.2001.117539_BIB15","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1073\/pnas.88.12.5350","article-title":"Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct","volume":"88","author":"Talaska","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mcn.2001.117539_BIB16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM198908243210815","article-title":"Bladder cancer after chemotherapy for non-Hodgkin`s lymphoma","volume":"321","author":"Travis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1067\/mcn.2001.117539_BIB17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3577477","article-title":"Radiation dose and second cancer risk in patients treated for cancer of the cervix","volume":"115","author":"Boice","year":"1988","journal-title":"Radiat Res"},{"key":"10.1067\/mcn.2001.117539_BIB18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0022-5347(01)63777-7","article-title":"Second primary malignancies in T1-3N0 prostate cancer patients treated with radiation therapy with 10-year follow-up","volume":"159","author":"Johnstone","year":"1998","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0094-0143(21)01095-8","article-title":"Histopathology and classification of urinary bladder carcinoma","volume":"3","author":"Friedell","year":"1976","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB20","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0022-5347(01)64687-1","article-title":"Screening cytoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder","volume":"17","author":"Navon","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB21","first-page":"310","article-title":"Pathology of carcinomas of the urinary bladder","author":"Young","year":"2000"},{"key":"10.1067\/mcn.2001.117539_BIB22","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M","article-title":"Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases","volume":"67","author":"Grignon","year":"1991","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(95)96490-8","article-title":"Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer","volume":"45","author":"Angulo","year":"1995","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R","article-title":"The usefulness of the level of the muscularis mucosae in the in the staging of invasive transitional cell carcinoma of the urinary bladder","volume":"66","author":"Younes","year":"1990","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB25","series-title":"Histological typing of urinary bladder tumors. International classification of tumors","author":"Mostofi","year":"1973"},{"key":"10.1067\/mcn.2001.117539_BIB26","series-title":"TNM classification of malignant neoplasms","author":"Sobin","year":"1997"},{"key":"10.1067\/mcn.2001.117539_BIB27","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasm of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1067\/mcn.2001.117539_BIB28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bmj.2.6078.29","article-title":"Haematuria diagnostic service","volume":"2","author":"Turner","year":"1977","journal-title":"BMJ"},{"key":"10.1067\/mcn.2001.117539_BIB29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.241.2.149","article-title":"Clinical importance of microhematuria","volume":"241","author":"Carson","year":"1979","journal-title":"JAMA"},{"key":"10.1067\/mcn.2001.117539_BIB30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0022-5347(17)55461-0","article-title":"Asymptomatic microscopic hematuria","volume":"124","author":"Golin","year":"1980","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.256.2.224","article-title":"Asymptomatic microhematuria and urologic disease: a population-based study","volume":"256","author":"Mohr","year":"1986","journal-title":"JAMA"},{"key":"10.1067\/mcn.2001.117539_BIB32","first-page":"391","article-title":"Prospective comparison of computed tomography and intravenous pyelography in the initial evaluation of asymptomatic microhematuria","volume":"165","author":"Gray","year":"2001","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF02926862","article-title":"CT in determining depth of infiltration of bladder tumors","volume":"7","author":"Salo","year":"1985","journal-title":"Urol Radiol"},{"key":"10.1067\/mcn.2001.117539_BIB34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0094-0143(05)70403-1","article-title":"What is new in bladder cancer imaging","volume":"24","author":"Barentsz","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB35","first-page":"17","article-title":"New methods for detection of bladder cancer","volume":"16","author":"Grossman","year":"1998","journal-title":"Semin Urol Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(01)61899-8","article-title":"Comparison of screening methods in the detection of bladder cancer","volume":"161","author":"Ramakumar","year":"1999","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB37","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO;2-6","article-title":"The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma","volume":"60","author":"Badalament","year":"1987","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0094-0143(05)70231-7","article-title":"Urine cytology: is it still the gold standard for screening?","volume":"27","author":"Brown","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5347(17)51695-X","article-title":"Superficial bladder cancer: progression and recurrence","volume":"130","author":"Heney","year":"1983","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB40","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G","article-title":"Urinary cytology and bladder cancer: the cellular features of transitional cell neoplasms","volume":"53","author":"Murphy","year":"1984","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB41","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-E","article-title":"Low grade transitional cell carcinoma of the bladder: Cytologic diagnosis by key features as identified by logistic regression analysis","volume":"74","author":"Raab","year":"1994","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0022-5347(01)64827-4","article-title":"Diagnostic accuracy of urinary cytology and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors","volume":"157","author":"Gregoire","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-5347(01)61920-7","article-title":"Editorial: do we have a prostate specific antigen for bladder cancer?","volume":"161","author":"Soloway","year":"1999","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(01)67054-X","article-title":"Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer","volume":"154","author":"Sarosdy","year":"1995","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0090-4295(97)00206-9","article-title":"Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder","volume":"50","author":"Leyh","year":"1997","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB46","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/S0022-5347(01)68167-9","article-title":"The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms","volume":"158","author":"Murphy","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5347(01)61918-9","article-title":"Noninvasive detection of bladder cancer with the BTA stat test","volume":"161","author":"Pode","year":"1999","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0090-4295(97)00508-6","article-title":"Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors","volume":"50","author":"Ellis","year":"1997","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-5347(01)65851-8","article-title":"Use of the new tumor marker, urinary NMP22, in the detection of occult or rapidily recurring transitional cell carcinoma of the urinary tract following surgical treatment","volume":"156","author":"Soloway","year":"1996","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(01)63930-2","article-title":"Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder","volume":"159","author":"Stampfer","year":"1998","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0022-5347(01)64321-0","article-title":"A multicenter trial evaluation of the fibrin\/fibrinogen degradation products test for detection and monitoring of bladder cancer","volume":"158","author":"Schmetter","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0094-0143(05)70234-2","article-title":"The HA-Haase urine test: a sensitive and specific method for detecting bladder cancer and evaluating its grade","volume":"27","author":"Lokeshwar","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB53","first-page":"17","article-title":"New methods for detection of bladder cancer","volume":"16","author":"Grossman","year":"1998","journal-title":"Semin Urol Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO;2-1","article-title":"Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity","volume":"82","author":"Kavaler","year":"1998","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jcb.240501307","article-title":"Natural history of early bladder cancer","volume":"161","author":"Bostwick","year":"1992","journal-title":"J Cell Biochem"},{"key":"10.1067\/mcn.2001.117539_BIB56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","article-title":"Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15 year outcome","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB57","first-page":"499","article-title":"Carcinoma in situ","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1464-410X.1975.tb04064.x","article-title":"Flat carcinoma in situ of bladder","volume":"47","author":"Riddle","year":"1976","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB59","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0959-8049(94)E0133-O","article-title":"Displasia in normal looking urothelium increases the risk of tumor progression in primary superficial bladder cancer","volume":"30","author":"Kiemeney","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(17)58916-8","article-title":"Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ","volume":"116","author":"Althausen","year":"1976","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB61","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10 year follow-up","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB62","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(17)45923-4","article-title":"Superficial bladder tumors: the importance of recurrence pattern following initial resection","volume":"135","author":"Fitzpatrick","year":"1986","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cyto.990140504","article-title":"Consensus review of clinical utility of DNA cytometry in bladder cancer","volume":"14","author":"Wheeless","year":"1993","journal-title":"Cytometry"},{"key":"10.1067\/mcn.2001.117539_BIB64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00256518","article-title":"DNA profile and tumor progression in patients with superficial bladder tumors","volume":"10","author":"Gustafson","year":"1982","journal-title":"Urol Res"},{"key":"10.1067\/mcn.2001.117539_BIB65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02934525","article-title":"Clinical DNA flow cytometry","volume":"1","author":"Tribukait","year":"1984","journal-title":"Med Oncol Tumor Pharmaeother"},{"key":"10.1067\/mcn.2001.117539_BIB66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/1078-1439(96)00031-2","article-title":"Prognostic significance of DNA ploidy in Ta\/T1 bladder cancer: a Southwest Oncology Group study","volume":"2","author":"de Vere White","year":"1996","journal-title":"Urol Onc"},{"key":"10.1067\/mcn.2001.117539_BIB67","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(96)90219-1","article-title":"Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer","volume":"27","author":"Tetu","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1067\/mcn.2001.117539_BIB68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-5347(01)62747-2","article-title":"Prognostic markers in bladder cancer: a contemporary review of the literature","volume":"160","author":"Stein","year":"1998","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jnci\/85.1.53","article-title":"nuclear overexpression of p53 protien in transitional cell bladder carcinoma: a marker for disease progression","volume":"85","author":"Sarkis","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mcn.2001.117539_BIB70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0094-0143(05)70236-6","article-title":"A critical analysis of the use of p53 as a marker for management of bladder cancer","volume":"27","author":"Olumi","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jcb.240501311","article-title":"Blood group antigens in normal and neoplastic urothelium","volume":"161","author":"Sheinfeld","year":"1992","journal-title":"J Cell Biochem"},{"key":"10.1067\/mcn.2001.117539_BIB72","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-5347(17)67163-5","article-title":"Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma","volume":"114","author":"Decenzo","year":"1975","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(17)55275-1","article-title":"Cell surface A,B or O (H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma","volume":"124","author":"Newman","year":"1980","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB74","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0022-5347(17)53982-8","article-title":"ABH isoantigens in stage 0 papillary transitional cell carcinoma of the bladder: Correlation with biological behavior","volume":"127","author":"D`Elia","year":"1982","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB75","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(197912)44:6<2099::AID-CNCR2820440621>3.0.CO;2-I","article-title":"ABH antigens in transitional cell tumors of the urinary bladder-correlation with clinical course","volume":"44","author":"Limas","year":"1979","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB76","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-5347(17)56462-9","article-title":"The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder","volume":"122","author":"Young","year":"1979","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-5347(17)55760-2","article-title":"Prediction of bladder tumor invasion with the mixed cell agglutination test","volume":"123","author":"Johnson","year":"1980","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB78","first-page":"139","article-title":"Blood group antigen expression in bladder tumors: immunohistochemical study of superficial bladder lesions","volume":"13","author":"Sarkis","year":"1994","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1067\/mcn.2001.117539_BIB79","first-page":"4113","article-title":"Blood group-related antigens in human urothelium: enhanced expression of precursors, LeX and LeY determinants in urothelial carcinoma","volume":"48","author":"Cordon-Cardo","year":"1988","journal-title":"Cancer Res"},{"key":"10.1067\/mcn.2001.117539_BIB80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(17)39935-4","article-title":"Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation","volume":"143","author":"Sheinfeld","year":"1990","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB81","first-page":"423A","article-title":"The Lewis X antigen as a predictor of tumor recurrence in high risk disease-free bladder cancer patients","volume":"147","author":"Sheinfeld","year":"1992","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB82","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0094-0143(21)00225-1","article-title":"Endoscopic applications of laser energy","volume":"13","author":"Smith","year":"1986","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB83","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000473240","article-title":"Endoscopic Nd: YAG laser application for destroying bladder tumors","volume":"7","author":"Hofstetter","year":"1981","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0094-0143(21)00415-8","article-title":"Laser surgery for transitional-cell carcinoma","volume":"19","author":"Smith","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/lsm.1900140303","article-title":"Use of the holmium:YAG laser for treatment of superficial bladder carcinoma","volume":"14","author":"Johnson","year":"1994","journal-title":"Lasers Surg Med"},{"key":"10.1067\/mcn.2001.117539_BIB86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-5347(17)59108-9","article-title":"Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder","volume":"115","author":"Kelly","year":"1976","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0094-0143(05)70244-5","article-title":"The role of photodynamic therapy in the treatment of recurrent superficial bladder cancer","volume":"27","author":"Walther","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB88","first-page":"2008","article-title":"Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells","volume":"45","author":"Mitchell","year":"1985","journal-title":"Cancer Res"},{"key":"10.1067\/mcn.2001.117539_BIB89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0094-0143(05)70240-8","article-title":"An overview of the treatment of superficial bladder cancer","volume":"27","author":"Duque","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB90","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-5347(17)36577-1","article-title":"Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European Organization for Research on Treatment of Cancer, randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin","volume":"148","author":"Bouffioux","year":"1992","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB91","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1464-410X.1994.tb07547.x","article-title":"The effect of intravesical thiotepa on tumor recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer: a further report with long-term follow-up of a Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer","volume":"73","year":"1994","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-5347(17)55018-1","article-title":"The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder","volume":"125","author":"Koontz","year":"1981","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002800050448","article-title":"Thiotepa pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumor","volume":"38","author":"Masters","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB94","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1001\/jama.244.18.2065","article-title":"Hematologic effects of intravesical thiotepa therapy for bladder carcinoma","volume":"244","author":"Hollister","year":"1980","journal-title":"JAMA"},{"key":"10.1067\/mcn.2001.117539_BIB95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0094-0143(21)00419-5","article-title":"Complications of intravesical chemotherapy","volume":"19","author":"Thrasher","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1464-410X.1976.tb02742.x","article-title":"Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma","volume":"48","author":"Burnand","year":"1976","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB97","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0090-4295(77)90101-7","article-title":"Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer","volume":"10","author":"Byar","year":"1977","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(17)56236-9","article-title":"A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thiotepa","volume":"122","author":"Nocks","year":"1979","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB99","first-page":"43","article-title":"The effects of intravesical instillation of thiotepa on the recurrence rate of bladder tumors","volume":"34","author":"Asahi","year":"1980","journal-title":"Acta Med Okayama"},{"key":"10.1067\/mcn.2001.117539_BIB100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000473519","article-title":"Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: An EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone","volume":"8","author":"Schulman","year":"1982","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB101","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-5347(17)52205-3","article-title":"Influence of thiopeta and doxorubicin instillation at the time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double blind, controlled trial","volume":"129","author":"Zincke","year":"1983","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB102","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0022-5347(17)51400-7","article-title":"Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa","volume":"130","author":"Prout","year":"1983","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB103","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1464-410X.1985.tb07031.x","article-title":"The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer: an MRC study","volume":"57","author":"Medical Research Council Working Party on Urological Cancer, London","year":"1985","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00686937","article-title":"A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer-intravesical thio-TEPA versus oral UFT","volume":"30","author":"Hirao","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0094-0143(21)00424-9","article-title":"Long-term results of intravesical therapy for superficial bladder cancer","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB106","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0022-5347(01)67427-5","article-title":"Apparent failure of current intravesical chemotherapy prophlaxis to influence the long-term cause of superficial transitional cell carcinoma of the bladder","volume":"153","author":"Lamm","year":"1995","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000464018","article-title":"Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer","volume":"17","author":"Flamm","year":"1990","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB108","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00262495","article-title":"Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer: prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group","volume":"20","author":"Akaza","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB109","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of doxorubicin and immunotherapy with Bacillus Calmette-Gu\u00c9rin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mcn.2001.117539_BIB110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00256725","article-title":"Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer","volume":"11","author":"Niijima","year":"1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-5347(17)42387-1","article-title":"Natural history and treatment of low and high risk superficial bladder tumors","volume":"139","author":"Rubben","year":"1988","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB112","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF00686928","article-title":"Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer","volume":"35","author":"Obata","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-5347(01)64484-7","article-title":"Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and tranurethral resection alone","volume":"158","author":"Kurth","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB114","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005392-199707000-00018","article-title":"Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study","volume":"158","author":"Ali-el-Dein","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1990.tb08268.x","article-title":"Dermatitis due to intravesical mitomycin C: a delayed type hypersensitivity reaction?","volume":"122","author":"Colver","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1067\/mcn.2001.117539_BIB116","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000474054","article-title":"Mitomycin instillation to prevent recurrence of superficial bladder carcinoma: Results of a controlled prospective study in 58 patients","volume":"9","author":"Huland","year":"1983","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB117","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-5347(17)41300-0","article-title":"Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor","volume":"141","author":"Kim","year":"1989","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB118","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","article-title":"The effect of intravesical mitomycin on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of follow-up","volume":"155","author":"Tolley","year":"1996","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB119","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-5347(01)65673-8","article-title":"A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: Transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Gu\u00c9rin","volume":"156","author":"Krege","year":"1996","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB120","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(01)61606-9","article-title":"Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short- and long-term follow-up","volume":"161","author":"Solsona","year":"1999","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB121","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/cncr.1980.45.s7.1856","article-title":"The management of superficial bladder cancer","volume":"45","author":"Soloway","year":"1980","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB122","first-page":"479","article-title":"Long-term results of intravesical prevention of recurrence with mitomycin C and Adriamycin in patients with superficial bladder cancer","volume":"33","author":"Schwaibold","year":"1994","journal-title":"Urologe A"},{"key":"10.1067\/mcn.2001.117539_BIB123","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0022-5347(17)38152-1","article-title":"Phase 12study of intravesical epirubicin in patients with carcinoma in situ of the bladder","volume":"146","author":"Kurth","year":"1991","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB124","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-5347(17)36198-0","article-title":"A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single-stage Ta, T1 papillary carcinoma of the bladder","volume":"149","author":"Oosterlinck","year":"1993","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB125","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1097-0142(19930901)72:5<1749::AID-CNCR2820720539>3.0.CO;2-8","article-title":"Intravesical 4\u2032-epidoxorubicin (epirubicin) versus bacillus Calmette-Gu\u00c9rin: a controlled prospective study on the prophylaxis of superficial bladder cancer","volume":"72","author":"Melekos","year":"1993","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB126","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1464-410X.1995.tb00759.x","article-title":"A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder: Finnish Multicentre Study Group","volume":"76","author":"Raitanen","year":"1995","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB127","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1464-410X.1996.08486.x","article-title":"Intravesical instillation of epirubicin: effect on tumor recurrence in patients with dysplastic epithelium after transurethral resection of superficial bladder tumour","volume":"77","author":"Igawa","year":"1996","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB128","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1464-410X.1997.00142.x","article-title":"Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study","volume":"79","author":"Ali-el-dein","year":"1997","journal-title":"Br J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF00686919","article-title":"Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial","volume":"35","author":"Eto","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1067\/mcn.2001.117539_BIB130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000019581","article-title":"A randomized study of short versus long-term intravesical epirubicin instillation for superficial bladder cancer","volume":"33","author":"Okimura","year":"1998","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB131","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-5347(01)64484-7","article-title":"Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a Euopean Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone","volume":"158","author":"Kurth","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB132","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(01)65396-5","article-title":"A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 Bladder Cancer","volume":"156","author":"Pawinski","year":"1996","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB133","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(69)92648-8","article-title":"Active immunotherapy for acute lymphoblastic leukaemia","volume":"1","author":"Mathe","year":"1969","journal-title":"Lancet"},{"key":"10.1067\/mcn.2001.117539_BIB134","first-page":"337","article-title":"Use of BCG in the treatment of human neoplasms: a review","volume":"1","author":"Nathanson","year":"1974","journal-title":"Semin Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB135","first-page":"127","article-title":"Extracutaneous delayed hypersensitivity, particularly in the guinea pig bladder","volume":"10","author":"Coe","year":"1966","journal-title":"J Immunol"},{"key":"10.1067\/mcn.2001.117539_BIB136","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB137","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00184040","article-title":"Strategy for improving therapy of superficial bladder cancer","volume":"9","author":"Ratliff","year":"1991","journal-title":"World J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB138","first-page":"4286","article-title":"Murine bladder carcinoma cells present antigen to BCG specific CD4+ T-cells","volume":"52","author":"Lattime","year":"1992","journal-title":"Cancer Res"},{"key":"10.1067\/mcn.2001.117539_BIB139","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000475203","article-title":"Improving the safety of BCG immunotherapy by dose reduction","volume":"27","author":"Marinez-Pineiro","year":"1995","journal-title":"Eur Urol"},{"key":"10.1067\/mcn.2001.117539_BIB141","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-5347(17)37532-8","article-title":"Dose response to bacillus Calmette-Gu\u00c9rin in the treatment of superficial bladder cancer","volume":"147","author":"Morales","year":"1992","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB142","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(01)65185-1","article-title":"Evolution and clinical significance of the T-cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Gu\u00c9rin during intravesical treatment of superficial bladder cancer","volume":"157","author":"Zlotta","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB143","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-5347(01)66424-3","article-title":"Urinary cytokines during intravesical bacillus Calmette-Gu\u00c9rin therapy for superficial bladder cancer","volume":"155","author":"de Reijke","year":"1996","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB144","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Gu\u00c9rin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-5347(17)42722-4","article-title":"Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors","volume":"139","author":"Kavoussi","year":"1988","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB146","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-5347(17)43959-0","article-title":"Risks and benefits of repeated courses of intravesical bacillus Calmette-Gu\u00c9rin therapy for superficial bladder cancer","volume":"137","author":"Catalona","year":"1987","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB147","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(17)45091-9","article-title":"Two courses of intravesical bacillus Calmette-Gu\u00c9rin for transitional cell carcinoma of the bladder","volume":"136","author":"Haaff","year":"1986","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB148","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)46972-2","article-title":"Bacillus Calmette-Gu\u00c9rin immunotherapy for bladder cancer","volume":"134","author":"Lamm","year":"1985","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0090-4295(85)90525-4","article-title":"Experience with intravesical bacillus Calmette-Gu\u00c9rin therapy of superficial bladder tumors","volume":"25","author":"Herr","year":"1985","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(17)45604-7","article-title":"Long-term effect of intravesical bacillus Calmette-Gu\u00c9rin on flat carcinoma in situ of the bladder","volume":"135","author":"Herr","year":"1986","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(17)37707-8","article-title":"A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: Is it effective?","volume":"146","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB152","first-page":"499","article-title":"Carcinoma in situ","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB153","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000281212","article-title":"A trial of bacillus Calmette-Gu\u00c9rin versus adriamycin in superficial bladder cancer: a Southwest Oncoclogy Group Study","volume":"41","author":"Mori","year":"1986","journal-title":"Urol Int"},{"key":"10.1067\/mcn.2001.117539_BIB154","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0022-5347(17)46969-2","article-title":"The use of bacillus Calmette-Gu\u00c9rin in the therapy of bladder carcinoma in situ","volume":"134","author":"Brosman","year":"1985","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB155","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.1988.6.9.1450","article-title":"Bacillus Calmette-Gu\u00c9rin therapy alters the progression of superficial bladder cancer","volume":"6","author":"Herr","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(17)37707-8","article-title":"A low dose bacillus Calmette-Gu\u00c9rin regimen in superficial bladder cancer therapy: is it effective?","volume":"146","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB157","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-5347(17)43125-9","article-title":"Single course versus maintenance bacillus Calmette-Gu\u00c9rin therapy for superficial bladder tumors: a prospective randomized trial","volume":"138","author":"Hudson","year":"1987","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB158","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1987.5.3.441","article-title":"A Prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Gu\u00c9rin therapy for superficial bladder cancer","volume":"5","author":"Badalament","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB159","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0094-0143(21)00423-7","article-title":"Complications of bacillus Calmette-Gu\u00c9rin immunotherapy","volume":"19","author":"Lamm","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1067\/mcn.2001.117539_BIB160","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Gu\u00c9rin in intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB161","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-5347(17)59919-X","article-title":"Immunologic reduction of bladder cancer recurrence rate","volume":"111","author":"Olson","year":"1974","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB162","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-5347(17)42610-3","article-title":"Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study","volume":"139","author":"Jurincic","year":"1988","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB163","first-page":"138","article-title":"Topical immunotherapy (KLH) vs chemotherapy (ethoglucid) in prevention of recurrence of superficial bladder cancer: a prospective randomized study","volume":"33","author":"Flamm","year":"1994","journal-title":"Urologe"},{"key":"10.1067\/mcn.2001.117539_BIB164","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-5347(17)39547-2","article-title":"A randomized controlled study of intravesical alpha-2b interferon in carcinoma in situ of the bladder","volume":"144","author":"Glashan","year":"1990","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB165","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0090-4295(96)00375-5","article-title":"BCG plus interferon alpha 2b in patients with superficial bladder cancer","volume":"48","author":"Stricker","year":"1996","journal-title":"Urology"},{"key":"10.1067\/mcn.2001.117539_BIB166","first-page":"152","article-title":"Co-administration of INF alpha 2b with low dose is effective in patients with superficial bladder cancer who failed BCG","volume":"163","author":"O`Donnell","year":"2000","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB167","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5347(17)34863-2","article-title":"Megadose vitamins in bladder cancer: a double-blind clinical trial","volume":"151","author":"Lamm","year":"1994","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB168","first-page":"289","article-title":"Indications for early cystectomy","volume":"18","author":"Stein","year":"2000","journal-title":"Sem Urol Oncol"},{"key":"10.1067\/mcn.2001.117539_BIB169","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/1097-0142(19950901)76:5<833::AID-CNCR2820760518>3.0.CO;2-M","article-title":"Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction","volume":"76","author":"Freeman","year":"1995","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-5347(17)34865-6","article-title":"Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder","volume":"151","author":"Amling","year":"1994","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB171","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/1097-0142(19940401)73:7<1926::AID-CNCR2820730725>3.0.CO;2-Q","article-title":"Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy","volume":"73","author":"Soloway","year":"1994","journal-title":"Cancer"},{"key":"10.1067\/mcn.2001.117539_BIB172","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-5347(17)38244-7","article-title":"Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification","volume":"145","author":"Pagano","year":"1991","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB173","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-5347(01)64487-2","article-title":"Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases","volume":"158","author":"Ghoneim","year":"1997","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB174","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-5347(17)37779-0","article-title":"Residual tumor discovered in routine transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder","volume":"146","author":"Klan","year":"1991","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB175","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/S0022-5347(01)66692-8","article-title":"Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results","volume":"154","author":"Pansadoro","year":"1995","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB176","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-5347(01)63731-5","article-title":"Correlation between p53 over expression and response to bacillus Calmette-Gu\u00c9rin therapy in a high risk select population of patients with T1G3 bladder cancer","volume":"159","author":"Lebret","year":"1998","journal-title":"J Urol"},{"key":"10.1067\/mcn.2001.117539_BIB177","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0090-4295(96)00624-3","article-title":"Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment","volume":"49","author":"Ick","year":"1997","journal-title":"Urol"},{"key":"10.1067\/mcn.2001.117539_BIB178","first-page":"289","article-title":"Indications for early cytectomy","volume":"18","author":"Stein","year":"2000","journal-title":"Semin Urol Onc"},{"key":"10.1067\/mcn.2001.117539_BIB179","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-5347(17)39544-7","article-title":"The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)","volume":"144","author":"Malkowicz","year":"1990","journal-title":"J Urol"}],"container-title":["Current Problems in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147027201000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147027201000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:29:07Z","timestamp":1680521347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147027201000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":179,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0147027201000320"],"URL":"https:\/\/doi.org\/10.1067\/mcn.2001.117539","relation":{},"ISSN":["0147-0272"],"issn-type":[{"value":"0147-0272","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}